Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.385NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.384NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.338NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BG.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.20.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XVNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.38.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.619.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.12.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.260NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.456NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.16 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.70NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.42NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.428NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.374NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.63 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.377NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.298NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.30.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.76NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.17.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.562NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.219NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
N.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XANWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.114NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.516NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.354NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.162NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.426NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.402NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.424NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.61NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.264NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.581NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19194.1South Korea
B.1.330NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used